- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VRTX
Recent news which mentions VRTX
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
February 10, 2025
Tickers
VRTX
From Motley Fool
Vertex Q4 Earnings On Deck: Will This Biotech Heavyweight Keep Its Edge?
February 10, 2025
From Benzinga
Top Wall Street Forecasters Revamp Vertex Pharmaceuticals Price Expectations Ahead Of Q4 Earnings
February 10, 2025
From Benzinga
US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst
February 10, 2025
From Benzinga
Earnings Scheduled For February 10, 2025
February 10, 2025
From Benzinga
McDonald's, ON Semiconductor And 3 Stocks To Watch Heading Into Monday
February 10, 2025
From Benzinga
2 Biotech Stocks to Buy Hand Over Fist in February
February 09, 2025
From Motley Fool
UnitedHealth, Vertex Pharmaceuticals, Axon Enterprise And A Major Energy Stock: CNBC's 'Final Trades'
February 06, 2025
From Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
February 04, 2025
From Benzinga
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
February 04, 2025
Tickers
VRTX
From Motley Fool
3 Magnificent Stocks to Buy and Hold Forever
February 03, 2025
From Motley Fool
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
February 02, 2025
Tickers
VRTX
From Motley Fool
From Motley Fool
FDA Approves First Non-Opioid Pain Pill, As Medical Marijuana Remains A Proven Alternative For Relief
January 31, 2025
From Benzinga
Vertex Pharmaceuticals Shares Are Up Today: What's Going On?
January 31, 2025
From Benzinga
Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday
January 31, 2025
From Benzinga
From Wall Street Pit
This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
January 30, 2025
From Benzinga
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
January 25, 2025
From Motley Fool
From Motley Fool
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever
January 21, 2025
From Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
January 20, 2025
From Benzinga
3 Unstoppable Stocks to Buy in 2025
January 18, 2025
From Motley Fool
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
January 16, 2025
From Benzinga
Tickers
VRTX
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.